Virtual clinical trials – Can this be the new normal?
November 25, 2020Our Insightsdigital health,COVID19,digital,virtualtrials
With the high severity and more significant contagion effect, this pandemic has…
Migraine treatments and what the future holds
November 24, 2020Our Insightsmigraine,headache,CNS
Migraine remains a condition with no cure and without a fully understood…
BioPharma Corporate Venture Capital Investment Trends (2020 edition)
November 21, 2020Our Insights,venture capitalinvestment,early stage,Venture Capital Trends
We recently analyzed the portfolios and activities of 22 BioPharma CVCs; you…
Patient centricity and how to achieve it
November 20, 2020Our Insightsdigital health,patients,patient centricity
Patient centricity is the act of designing a service or solution around…
How an emerging HealthTech Company created a better-informed business strategy
November 4, 2020digital health,Case studies,smart devices,case studyour work
The challenge: Emerging HealthTech struggling with competitive intelligence and…
How a Top-10 Pharma got ahead of the competition and developed TA-targeted patient solutions.
November 4, 2020Case studiespatients,solutions,healthcare consulting,case study,our work
The challenge: How do we address patients’ unmet needs? A Top-10 Pharmaceutical…
Big Data and AI: how to do it right
October 28, 2020Our Insightsdigital health,big data,AI
Data has been described many times as “the new oil” but this statement doesn’t…
Privacy concerns in a digital healthcare space
October 28, 2020Our Insightsdigital health,digital
In the era of social media platforms and AI technology, digital healthcare is…
How increased use of Digital is expected to improve healthcare delivery
October 27, 2020Our Insightsdigital health,at-home healthcare
Healthcare is rapidly changing and this typically means that innovation is at…
A view of Digital Health in EU
September 28, 2020Our Insightsdigital health,big data,AI,Europe
Generally speaking, EMA focuses on innovation across the product development…
The curious case of biosimilar launches in the US
June 23, 2020Our Insightsbiosimilars,market access,biologics
The Biologics Price Competition and Innovation Act (BPCI Act) of 2009 provided…
Treatment paradigm analysis in haematology
May 12, 2020Case studiesHaematology
LucidQuest was asked to support a haematology brand team of a large…











